MCM3AP and laryngotracheoesophageal cleft: In conclusion, MCM3AP-AS1 expression was markedly elevated in breast cancer (Chen et al., 2020; Riahi et al., 2021), Burkitt lymphoma (Guo et al., 2020), gastric cancer (Wang et al., 2020; Sun et al., 2021), glioblastoma (Yang et al., 2017), HCC (Wang et al., 2019e), LC (Li et al., 2020b), nasopharyngeal carcinoma (Sun et al., 2020), pancreatic cancer (Yang et al., 2019), papillary thyroid cancer (Liang et al., 2019), and PCa (Li et al., 2020a; Wu et al., 2020).